Minerva Neurosciences (NERV) Notes Payables (2013 - 2018)

Minerva Neurosciences has reported Notes Payables for 6 years, with the latest figure at $1.4 million in Q2 2018.

• For the quarter ending Q2 2018, Notes Payables fell 72.43% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2018 stood at $1.4 million (down 72.43% YoY), and the FY2017 full-year result was $4.0 million, down 18.36% from the prior year.
• Notes Payables for Q2 2018 stood at $1.4 million, down from $2.7 million in the prior quarter.
• The five-year high for Notes Payables was $5.2 million in Q3 2017, with the low at $158263.0 in Q1 2015.
• Historically, Notes Payables has averaged $3.0 million across 5 years, with a median of $2.7 million in 2018.
• Annual changes were most pronounced in 2016 — Notes Payables jumped 1788.21% — and 2018, when it sank 72.43%.
• Minerva Neurosciences' Notes Payables stood at $2.0 million in 2014, then slipped by 28.53% to $1.4 million in 2015, then jumped by 238.3% to $4.9 million in 2016, then declined by 18.36% to $4.0 million in 2017, then tumbled by 64.75% to $1.4 million in 2018.
• The last three Notes Payables figures came in at $1.4 million (Q2 2018), $2.7 million (Q1 2018), and $4.0 million (Q4 2017), per Business Quant data.